// App-Quantinova.ai

: Long-Term Burden of Hemocompatibility Related Adverse Events in the MOMENTUM 3 Trial: Final Analysis of the 1028 Patient Cohort

Researchers

Presenter

  • N. Uriel

Principal Investigators

  • M. Mehra

Medical Centers

  • The University of Chicago Medical Center, Chicago, IL

  • Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Adaptive

  • Controlled

  • Cohort

Phase

  • NA

Study Id's

  • NCT02224755

Sponsors

  • Abbott Laboratories

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved